Acthar and Taste - impaired - a phase IV clinical study of FDA data

Summary:

Taste - impaired is reported as a side effect among people who take Acthar (corticotropin), especially for people who are female, 50-59 old, have been taking the drug for < 1 month also take Tacrolimus, and have Multiple sclerosis relapse.

The phase IV clinical study analyzes which people have Taste - impaired when taking Acthar. It is created by eHealthMe based on reports of 4,932 people who have side effects when taking Acthar from the FDA, and is updated regularly.

What is Acthar?

Acthar has active ingredients of corticotropin. eHealthMe is studying from 4,948 Acthar users. Check the latest studies of Acthar.

What is Taste - impaired?

Taste - impaired is found to be associated with 1,828 drugs and 3,111 conditions by eHealthMe. Check the latest studies of Taste - impaired.

On Jul, 15, 2026

4,932 people reported to have side effects when taking Acthar.
Among them, 21 people (0.43%) have Taste - impaired.

Among these 21 people:

How long have people been on Acthar when they have Taste - impaired? *

What is the gender of people who have Taste - impaired when taking Acthar? *

female: 80.95 %
male: 19.05 %

What is the age of people who have Taste - impaired when taking Acthar? *

What are other drugs people take besides Acthar? *

What are other side effects people have besides Taste - impaired? *

Nausea (feeling of having an urge to vomit): 8 people, 38.10%
Feeling Abnormal: 8 people, 38.10%
Dry Mouth: 8 people, 38.10%
Headache (pain in head): 7 people, 33.33%
Rashes (redness): 6 people, 28.57%
Skin Discoloration: 5 people, 23.81%
Muscle Tightness: 5 people, 23.81%
Heart Palpitations (feelings or sensations that your heart is pounding or racing): 5 people, 23.81%
Allergy To Arthropod Sting: 4 people, 19.05%
Skin Infection: 4 people, 19.05%

What are the existing conditions these people have? *

Pemphigoid (tense blisters on the skin): 4 people, 19.05%
Osteoarthritis (a joint disease caused by cartilage loss in a joint): 4 people, 19.05%
Nephrotic Syndrome (kidney disease with proteinuria, hypoalbuminemia, and oedema): 4 people, 19.05%
Iridocyclitis (inflammation of the iris and ciliary body of the eye): 4 people, 19.05%
Multiple Sclerosis Relapse (reoccurrence of a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 4 people, 19.05%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 3 people, 14.29%
High Blood Pressure: 2 people, 9.52%
Uveitis (inflammation of the uvea): 1 person, 4.76%
Itching: 1 person, 4.76%
Blood Pressure Abnormal: 1 person, 4.76%

* Approximation only. Some reports may have incomplete information.

Do you take Acthar and have Taste - impaired?

- Check whether Taste - impaired is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Acthar:

Acthar (4,948 reports)

Taste - impaired treatments and more:

Taste - impaired (83,126 reports)

Browse all side effects of Acthar:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Taste - impaired:

Taste - impaired (1,828 drugs)

Browse all the conditions that are associated with Taste - impaired:

Taste - impaired (3,111 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on corticotropin (the active ingredients of Acthar) and Acthar (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.